The Fastest-Growing Robotics Companies in Healthcare
Surgical robotics is on track to double to over $22 billion by 2029. The companies driving it, from Intuitive Surgical to fast-rising challengers, and what it means for reps.
*Publishing note for launch: every company name below (shown in bold) should link to its Vocari platform company page.*
Only about one in forty major surgeries in the US is done with a robot today. That is the whole investment case. Surgical robotics is a market with a long runway, growing about 15 percent a year toward more than $22 billion by 2029, and nearly every major device company is racing to claim a piece.
For a rep, robotics is where the growth, the new territories, and the promotions are concentrated. Here are the companies driving it, and what makes each one worth watching.
How big is the surgical robotics market?
The global robotic-surgery market ran about $11 billion in 2024 and is projected to reach roughly $22 billion by 2029, a growth rate near 15 percent a year. Yet only about 2.5 percent of major US operating-room procedures are robot-assisted, and under 10 percent worldwide.
That gap between adoption today and the room to grow is why capital is pouring in, and why robotics roles are multiplying across the industry.
Who dominates surgical robotics?
Intuitive Surgical owns the category. Its da Vinci system holds roughly 75 percent of the global market on about $8 billion in annual robotics revenue, with a new da Vinci 5 rolling out and its Ion lung-biopsy platform expanding. Its share is projected to climb toward 82 percent by 2029.
For reps, Intuitive is both the benchmark and the biggest robotics employer in the space. Selling against or alongside da Vinci is a defining feature of the category.
Which robotics companies are growing fastest?
The most explosive growth is coming from challengers and new entrants:
- SS Innovations grew revenue more than 100 percent in its latest year, to about $42 million, on its lower-cost SSi Mantra robot, and filed for US clearance in late 2025 after pioneering long-distance telesurgery in India.
- Medtronic won its first US clearance for the Hugo system, in urology, in late 2025, and says Hugo procedure volume more than doubled year over year.
- Stryker keeps extending its Mako lead in orthopedics, with an install base now past 3,000 systems and new knee, hip, and shoulder applications.
- Zimmer Biomet is expanding its Rosa platform and acquiring Monogram for semi-autonomous knee replacement.
- PROCEPT BioRobotics is scaling Aquablation therapy for enlarged prostate through its HYDROS robotic system, a fast-rising name in urology robotics.
- Noah Medical is expanding its Galaxy System for robotic-assisted bronchoscopy in early lung-cancer diagnosis, and has passed 5,000 procedures.
Add Johnson & Johnson MedTech, whose Ottava soft-tissue robot is in development, and it is clear the incumbents are all-in on catching the leader.
What does robotics growth mean for a sales career?
Fast-growing categories create openings. Robotics companies are hiring clinical specialists, capital reps, and associate reps to support new placements and drive utilization, and new-entrant momentum tends to open fresh territories before the market saturates.
The trade is that robotics selling is technical and capital-heavy, with longer sales cycles and deep clinical support required. Reps who invest in the clinical and technical fluency tend to find robotics one of the more durable and better-paying places to build.
Key Takeaways
- Surgical robotics is growing about 15 percent a year toward more than $22 billion by 2029.
- Only about 2.5 percent of major US surgeries are robot-assisted, leaving a long runway.
- Intuitive Surgical dominates with roughly 75 percent share on about $8 billion in robotics revenue.
- SS Innovations (+100 percent), Medtronic's Hugo, and Stryker's Mako are among the fastest-moving.
- Robotics concentrates hiring, open territories, and promotions, in exchange for technical, capital-heavy selling.
Frequently Asked Questions
What is the fastest-growing area of medical devices?
Surgical robotics is among the fastest-growing areas, projected to roughly double to more than $22 billion by 2029 at about 15 percent annual growth. Adoption is still low, with only about 2.5 percent of major US procedures robot-assisted, which leaves substantial room to expand.
Which company leads in surgical robotics?
Intuitive Surgical, maker of the da Vinci system, leads by a wide margin with roughly 75 percent of the global robotic-surgery market on about $8 billion in annual robotics revenue. Its share is projected to keep rising toward 82 percent by 2029 as the da Vinci 5 rolls out.
Which robotics companies are growing fastest?
Challengers and new entrants are growing fastest. SS Innovations grew revenue more than 100 percent on its lower-cost SSi Mantra robot, Medtronic's Hugo won US clearance and more than doubled procedure volume, and Stryker's Mako continues to extend its orthopedic lead past 3,000 installed systems.
Is surgical robotics a good field for sales reps?
It can be. Robotics concentrates much of the industry's growth, hiring, and open territories, and it tends to pay well because it is capital-heavy. The trade is that the selling is technical, the sales cycles are longer, and deep clinical support is expected, so it rewards reps willing to build real technical fluency.
Related Reading
- The Best Orthopedic Device Companies to Work For
- The Medical Device Companies Every New Rep Should Know
- The 2026 Medical Sales Salary Guide
About This Series
This guide is part of Vocari Intelligence, The Lobby’s series on how the medical sales business actually works, built from company financials and market data.
Want in on robotics? Set your parameters once on [Vocari](https://www.myvocari.com) and let matching roles come to you.